SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2369[Velcade + purine nucleoside analogues versus CLL] >>Eur J Haematol. 2005tuck-4/11/2005
2368Key Data on VELCADE(R) (Bortezomib) for Injection in Front-Line Studies and Beyobob zagorin-4/8/2005
2367Synta Pharmaceuticals Announces Key Senior Additions to Business and Scientific Icebrg-4/8/2005
2366<i>From forbes.com via Yahoo</i> Genius For Hire Zina Moukheiber, tnsaf-4/8/2005
2365Target Price Updates Symbol Broker From To Date MLNM Major Broker 3bob zagorin-4/7/2005
2364Millennium Pharmaceuticals "equal weight," target price reduced ThursIcebrg-3/31/2005
2363[NF-kappaB regulates GADD45beta expression during acute inflammation] >>Jtuck-3/31/2005
2362GS: MLNM (IL/N): Velcade approved in 2nd line multiple myeloma, as expected. Maimopgcw-3/30/2005
2361full release includes some data on the trial... Millennium to Discuss Full Apprbob zagorin-3/28/2005
2360Millennium to Discuss Full Approval of VELCADE(R) (bortezomib) for Injection in Ian@SI-3/28/2005
2359[Targeting BCL-2 overexpression in malignancies through NF-kappaB inhibition by tuck-3/27/2005
2358Oblique reference to MLNM in Barron's: online.barrons.com Last week, the FIan@SI-3/27/2005
2357FDA Grants Full Approval for VELCADE(R) (Bortezomib) for Injection; Claims IncluIcebrg-3/25/2005
2356That’s ok Tomislav; I made killings on a biotechnology. For now I think I can akokoroko-3/19/2005
2355EU experts back wider use of Merck, J&J drugs Thu Mar 17, 2005 12:59 PM ET bob zagorin-3/17/2005
2354EU CHMP has just recommended that Velcade be adopted as secondline therapy in MMboronate-3/17/2005
2353Tomislav, but it's over 5 buckstom pope-3/16/2005
2352Miljenko, Do you have in mind any particular brand?kokoroko-3/16/2005
2351Bik, Bim and Bortezomib. The proteasome inhibitor bortezomib sensitizes cells tIcebrg-3/16/2005
2350from zacks.. EPS Estimate Revisions Symbol Broker Revision Period Period Endbob zagorin-3/15/2005
2349Millennium Announces Senior Executive Appointments --Expands Key Leadership Rolebob zagorin-3/14/2005
2348<6pack beer!> Please don't put me in placebo group! Thanks! Zetazeta1961-3/11/2005
2347[Bortezomib in combination with dexamethasone for relapsed multiple myeloma] &gtuck-3/11/2005
2346<<Have you got anything good to recommend below $5?>> 6-pack beer!Miljenko Zuanic-3/10/2005
2345SG Cowen & Co. 25th Annual Healthcare Conference to Webcast Millennium Presebob zagorin-3/10/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News